Abstract: The following is a description of the training offered to extracorporeal life support (ECLS)-trained staff at the Penn State Hershey Children’s Hospital. Changes with the ECLS circuit prompted the need for an initiative to train staff in the care of patients requiring ECLS support. In addition to didactic material, we incorporated a “hands-on” approach in designing the education. During the didactic portion, the circuit was demonstrated as a wet lab. The final step offered a voluntary visit... Show More
Full-text available · Article · Nov 2010 · Artificial Organs
Abstract: The objectives of this review are to describe the Extracorporeal Life Support (ECLS) research at the Penn State Pediatric Cardiovascular Research evaluating new pediatric ECLS components and to discuss a proposed continuous quality improvement model after implementation of new technology. Review of current literature pertaining to studies at the Penn State Hershey Children's Hospital (PSHCH) is presented along with a retrospective chart review of ECLS pediatric patients from January 2000 to... Show More
Full-text available · Article · Sep 2011 · Artificial Organs
Abstract: The objective of this investigation is to describe recent changes made in extracorporeal life support (ECLS) technology in the US Postal survey to directors and coordinators of all 125 US ECLS centers identified by Extracorporeal Life Support Organization as of November 2010, with follow-up of nonrespondents. Spearman coefficients were used to correlate the method of updating knowledge of ECLS technology with the likelihood of changing technology, and to correlate decision-making hierarchy... Show More
Full-text available · Article · May 2012 · Artificial Organs
Total priming volume is less than 190 ml, set-up time less than 10 min and 24/7 monitoring is not required. A pediatric ICU nurse uses the ECLS system, not a perfusionist or a respiratory therapist . All components have been tested in vitro at our Pediatric Cardiovascular Research Center3458,9,11,24,25].
[Show abstract] [Hide abstract] ABSTRACT: Extracorporeal life support (ECLS) and mechanical circulatory support (MCS) have become indispensable treatment tools for pediatric patients with congenital heart defects undergoing peri-operative or end-stage heart and/or lung failure. ECLS and MCS can serve as bridges to recovery, transplantation (heart or lung), destination therapy, or "bridge to bridge" long-term MCS. Dependent on patient condition, venoarterial ECMO (V-A ECMO) for heart and lung support, venovenous ECMO (V-V ECMO) for respiratory support, and MCS for uni- and biventricular support can be selected properly. Considering small patient body size, the access sites and cannulation should be selected carefully to obtain adequate blood flow, minimum injury, and easy management. The applying equipment, including tubing, cannulae, oxygenator and blood pump, need to be selected optimally in order to enable rapid setup and priming, successful cannulation and early support, and to reduce the risk of device-related morbidity and mortality. The aim of this review manuscript was to discuss briefly the current devices for pediatric ECLS and MCS available in US.
There are few devices designed for the paediatric population. A recent US survey showed that roller-pumps are still in use in 70% of neonatal and paediatric ECLS . However, the use of centrifugal pump systems in ECLS has improved patient safety and outcome .
[Show abstract] [Hide abstract] ABSTRACT: OBJECTIVES Mechanical circulatory support (MCS) is a rescue therapy for infants and children suffering from severe cardiorespiratory
failure with specific system-related complications like bleeding, thromboembolism and device failure. Novel circuit components
for temporary MCS with improved haemodynamic properties may improve patients' outcome and reduce system-related morbidities.
The Deltastream® DP3 (Medos Medizintechnik AG, Stolberg, Germany) is a newly designed rotational pump with a diagonally streamed
impeller that can be used in children of all ages (priming volume 16 ml, flow 0–8 l/min). The aim of this study was to analyse
the feasibility and safety of the DP3 pump system in children.